Table 2.
Summary Statistics – Medications
| Variables | Not Readmitted | Readmitted |
|---|---|---|
| mean (sd) | mean (sd) | |
| Medication Administration Route/Type Count | ||
| Inhalation | 0.37 (0.99) | 0.30 (0.91) |
| Injectable | 2.14 (4.08) | 2.61 (4.91) |
| Intramuscular | 0.15 (0.44) | 0.09 (0.41) |
| Intravenous | 1.55 (3.18) | 2.16 (4.31) |
| Ophthalmic | 0.13 (0.44) | 0.08 (0.41) |
| Oral | 2.01 (3.27) | 2.75 (4.42) |
| Rectal | 0.14 (0.44) | 0.11 (0.42) |
| Topical | 0.31 (0.73) | 0.38 (0.89) |
| Generic Medications | ||
| Acetaminophen | 0.43 (0.71) | 0.39 (0.71) |
| Acetaminophen hydrocodone | 0.05 (0.25) | 0.04 (0.21) |
| Albuterol | 0.18 (0.54) | 0.13 (0.43) |
| Cefazoline | 0.10 (0.38) | 0.08 (0.33) |
| Ceftriaxone | 0.07 (0.31) | 0.07 (0.29) |
| Dexamethasone | 0.08 (0.34) | 0.11 (0.43) |
| Diphenhydramine | 0.11 (0.39) | 0.22 (0.53) |
| Docusate | 0.04 (0.23) | 0.06 (0.26) |
| Epinephrine | 0.05 (0.25) | 0.07 (0.30) |
| Erythromycin ophthalmic | 0.07 (0.25) | 0.02 (0.12) |
| Fentanyl | 0.16 (0.45) | 0.14 (0.45) |
| Glycopyrrolate | 0.05 (0.24) | 0.05 (0.24) |
| Heparin | 0.17 (0.54) | 0.33 (0.74) |
| Hepatitis B vaccine | 0.06 (0.24) | 0.01 (0.12) |
| Ibuprofen | 0.14 (0.39) | 0.09 (0.32) |
| Ketorolac | 0.07 (0.29) | 0.05 (0.24) |
| Lidocaine | 0.08 (0.31) | 0.07 (0.30) |
| Lidocaine topical | 0.11 (0.33) | 0.14 (0.36) |
| Lorazepam | 0.07 (0.31) | 0.14 (0.42) |
| LVP solution | 0.48 (1.01) | 0.72 (1.40) |
| LVP solution with potassium | 0.20 (0.45) | 0.21 (0.48) |
| Midazolam | 0.12 (0.40) | 0.12 (0.40) |
| Morphine | 0.20 (0.56) | 0.19 (0.58) |
| Ondansetron | 0.20 (0.48) | 0.29 (0.59) |
| Oxycodone | 0.05 (0.24) | 0.06 (0.28) |
| Phytonadione | 0.08 (0.27) | 0.03 (0.18) |
| Polyethylene glycol 3350 | 0.05 (0.23) | 0.10 (0.30) |
| Potassium chloride | 0.07 (0.32) | 0.12 (0.43) |
| Propofol | 0.10 (0.35) | 0.10 (0.36) |
| Ranitidine | 0.07 (0.30) | 0.11 (0.37) |
| Rocuronium | 0.05 (0.23) | 0.04 (0.22) |
| Sodium chloride | 0.19 (0.54) | 0.25 (0.65) |